-
Price Momentum
CHGA is trading near the bottom of its 52-week range and below its 200-day simple moving average.
-
Price change
The price of CHGA shares has decreased $0.01 since the market last closed. This is a 1.51% drop.
-
Closed at $0.84.
The stock has remained unchanged in after-hours trading.
Key terms
About CHGA
Change Agents Corp. is a clinical-stage biotechnology company, which engages in the development of immune effector cell therapy and laboratory services. It operates through the Real Property Operating and Medical Related Consulting Services segments. The Real Property Operating segment includes property management fees, property insurance, real estate taxes, depreciation, repairs and maintenance fees, utilities and other expenses related to rental properties. The Medical Related Consulting segment relates to labor and related benefits, travel expenses, and related to consulting services. The company was founded on July 28, 2014 and is headquartered in Freehold, NJ.
-
Market cap: $1.05M
A market capitalization up to $300 million places CHGA in the micro-capitalization category.
Key terms
Smart score
Latest CHGA news
CHGA Financials
-
CHGA total_revenue: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
Net income: -$18.15M (1Y), -$2.18M (Q2)
Net Income decreased 129.68% since last year and increased 50.22% since last quarter.
-
Earnings per share: -$113.07 (1Y), -$2.76 (Q2)
EPS increased 33.0% since last year and increased 72.39% since last quarter.
Key terms
CHGA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CHGA Competitors
-
How competitors are chosen
CHGA's competitors are included in the Health Technology sector and Biotechnology group
-
Market cap: $1.05M
A market capitalization up to $300 million places CHGA in the micro-capitalization category.
